obesity-2016_posters-accepted-abstracts

6 / 11

Volume 6, Issue 9(Suppl) J Obes Weight Loss Ther 2016
ISSN: 2165-7904 JOWT, an open access journal
Page 54
Obesity 2016
December 08-10, 2016
conferenceseries.com
Obesity & Weight Management
December 08-10, 2016 Dallas, USA
10th International Conference and Exhibition on
J Obes Weight Loss Ther 2016, 6:9(Suppl)
How did an albino patient lose 148 lbs of weight? A case report
Zarnain Shah1, Samaneh A Motanagh2 and Syed Wajih Rizvi3
1Liaquat University of Medical & Health Sciences, Pakistan
2Ankara University School of Medicine, Turkey
3R-Endocrinology, USA
Introduction: Obesity is a highly prevalent and yet the most neglected disease. The number of overweight and obese people reached
2.3 billion and 700 million worldwide respectively, by the year 2015. Obesity is not a social disgrace but an actual disease with a major
genetic component to its etiology. Obesity treatment is a lifelong task. Weight reduction medications should be used as an adjunct
for diet restriction, exercise and behavioral modifications, when these measures alone have not resulted in adequate weight loss. We
hereby present a case of a morbidly obese male patient with oculocutaneous albinism who has lost 148 lbs of weight. Furthermore,
the report highlights the genetic link between oculocutaneous albinism and obesity.
Case Presentation: A 28-year-old male with oculocutaneous albinism presented with 361.8 lbs of weight (BMI: 62.1) and complaint
of difficulty in losing weight. Physical examination revealed hypertension, low intelligence, gynecomastia and infantile testicles. Lab
investigations showed unregulated hyperlipidemia and hypotestosteronemia. The patient was prescribed Xenical (Orlistat) 120 mg.
Over the period of five years, he lost 83.8 lbs. After this time, Xenical’s effectiveness was significantly reduced. Consequently, the
patient was given on Victoza (Liraglutide) on which he lost 64 lbs in three years. Thus, a sum of 147.8 lbs of weight was lost without
any side effects of the drugs.
Discussion: Obesity needs to be treated within the healthcare system as any other complex disease. We observed Xenical and Victoza
to be safe and effective in reducing obesity. Substantial literature has emerged to show that in both oculocutaneous albinism and
Prader-Willi syndrome (the most common genetic cause of obesity) where the P gene is mutated on Chromosome 15. This highlights
the genetic susceptibility of our albino patient for developing morbid obesity.
Conclusion: Obesity develops from the interplay of both genetic and environmental factors. This case clearly illustrates that Xenical
and Victoza can be safe and efficient for weight loss in a morbidly obese patient. Furthermore, scientific research in the genetic aspects
of obesity can help develop new strategies towards its prevention and treatment.
Frequency of consumption pattern of beverages among civil servants in Ogun State
Nupo Sunday Sedodo
Moshood Abiola Polytechnic, Nigeria
Beverage consumption is commonly found among the elites in the society. This study aimed to determine the frequency of beverage
consumption among the civil servants in the state. A cross sectional study was carried out among randomly selected 500 civil
servants in Abeokuta Ogun State. Anthropometric measurement was used to determine the nutritional status. The blood pressure
was measured using sphygmomanometer. A validated structured questionnaire was used obtain information on the beverage
consumption. The result of the anthropometric measurements study showed that 11% of the subjects were obese while 45% were
overweight. Only four percent of the subjects had hypertension. The result of the frequency of consumption of beverages revealed
that there were significant differences between male and female (p<0.005). The study showed that there is strong correlation between
beverage consumption and development of chronic non communicable diseases.